Postmenopausal Estrogen/Progestin Interventions(English)

• a clinical trial (1995) that concluded: Estrogen alone or in combination with a progestin improves lipoproteins and lowers fibrinogen levels without detectable effects on postchallenge insulin or blood pressure. Unopposed estrogen is the optimal regimen for elevation of HDL-C, but the high rate of endometrial hyperplasia restricts use to women without a uterus. In women with a uterus, CEE with cyclic MP has the most favorable effect on HDL-C and no excess risk of endometrial hyperplasia
• CEE, CVD, HDL-C, MPA
• Estrogen, Clinical trials, Menopause, Risk factor
• https://doi.org….03520270033028